PODD: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/051121b4-ed04-4248-84d7-b2f484b75619/","filing_uuid":"051121b4-ed04-4248-84d7-b2f484b75619","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/051121b4-ed04-4248-84d7-b2f484b75619/print/","filing_document_content_type":"text/html","income":null,"expenses":"220000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Al Lytton","dt_posted":"2026-07-20T11:46:20-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"100 Nagog Park","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Acton","registrant_state":"MA","registrant_zip":"01720","registrant":{"id":401106278,"url":"https://lda.gov/api/v1/registrants/401106278/","house_registrant_id":null,"name":"INSULET CORPORATION","description":"Medical device manufacturing, innovative medical technologies","address_1":"100 Nagog Park","address_2":null,"address_3":null,"address_4":null,"city":"Acton","state":"MA","state_display":"Massachusetts","zip":"01720","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AL LYTTON","contact_telephone":"+1 978-932-2867","dt_updated":"2026-07-20T10:12:59.734251-04:00"},"client":{"id":212277,"url":"https://lda.gov/api/v1/clients/212277/","client_id":12,"name":"INSULET CORPORATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-10-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the disease of diabetes, diabetes therapies, automated insulin delivery devices, and management of the disease of diabetes. Issues related to medical devices and medical device technologies. Issues related to Pharmacy Benefit Manager (PBM) reform proposals, PBM transparency and potential PBM proposals related to talks of future budget reconciliation package. Issues related to the reintroduction of the DIABETES Act (S.4037) in the 119th Congress. Issues related to artificial intelligence (AI) and predictive algorithms in medical devices and medical device technology. Issues related to tariffs and trade and the Sec. 232 Tariff investigation related to Medical Devices. Issues related to Local Coverage Determination revisions specifically in pathways for Continuous Glucose Monitors (CGM). Issues related to National Coverage Determination revisions specifically in reference to durable infusion insulin pumps. Issues related to Prior Authorizations in Medicare Advantage plans. Issues related to support of Improving Seniors' Timely Access to Care Act. Issues related to CMS finalized rule, DMEPOS Home Health Rule. Issues related to expansion of Competitive Bidding Program and implementation of CMS finalized rule relating to DMEPOS Home Health Rule. Issues related to combatting fraud, waste and abuse in the Medicare program - specifically related to the way continuous glucose monitors are billed in Medicare and potential solutions to vet durable medical equipment vendors at CMS. Issues related to wearable health care devices.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":109874,"prefix":null,"prefix_display":null,"first_name":"AL","nickname":null,"middle_name":null,"last_name":"LYTTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}